Myelinopathia centralis diffusa (vanishing white matter disease) in a four-year-old boy

J K Sinzig1, A Seitz, K Brockmann

  • 1University Children's Hospital, Mannheim, Germany. ju.k.sinzig@web.de

Insights

A rare childhood leukoencephalopathy, vanishing white matter disease, presents with ataxia and distinctive MRI findings. Elevated glycine in cerebrospinal fluid aids diagnosis of this myelin disorder.

Area of Science:

  • Pediatric Neurology
  • Neuroimaging
  • Metabolic Disorders

Background:

  • Leukoencephalopathies are a group of rare genetic disorders affecting white matter in the brain.
  • Childhood-onset leukoencephalopathies often present with progressive neurological deficits.
  • Accurate diagnosis relies on a combination of clinical presentation, neuroimaging, and biochemical markers.

Observation:

  • A four-year-old boy exhibited moderate ataxia following minor head trauma.
  • Cranial MRI revealed severe cerebral white matter signal changes, isointense with cerebrospinal fluid (CSF) across all pulse sequences.
  • Proton MR spectroscopy showed a generalized decrease in white matter metabolites.

Findings:

  • Cerebrospinal fluid (CSF) analysis detected elevated glycine levels.
  • The combination of clinical symptoms, MRI, MR spectroscopy, and elevated CSF glycine is characteristic of a specific leukoencephalopathy.
  • This condition was initially termed myelinopathia centralis diffusa and is now known as vanishing white matter disease.

Implications:

  • Recognition of this distinct pattern aids in the early diagnosis of vanishing white matter disease.
  • Understanding the characteristic neuroimaging and biochemical profile is crucial for differentiating it from other childhood white matter disorders.
  • Further research into the pathophysiology and potential treatments for this myelin disorder is warranted.